Drugs / TPI 1020
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00483743 | Nov 2007 → Dec 2008 | chronic obstructive pulmonary disease | Syntara | Completed | No outcome recorded |
| Phase 2 | NCT00327808 | May 2006 → Mar 2007 | asthma | Syntara | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TPI 1020 | “This study will assess and compare the safety and tolerability of inhaled TPI 1020 versus budesonide.” NCT00327808 ↗ |
| Known as | NCX 1020 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068528 ↗ |
| Modality | Small molecule | — CHEMBL6068528 ↗ |
| Route | Inhaled | “Inhaled TPI-1020” NCT00327808 ↗ |